- Home
- EAT vs CORT Comparison
EAT vs CORT Comparison
Compare EAT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAT
- CORT
- Stock Information
- Founded
- EAT 1975
- CORT 1998
- Country
- EAT United States
- CORT United States
- Employees
- EAT N/A
- CORT N/A
- Industry
- EAT Restaurants
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- EAT Consumer Discretionary
- CORT Health Care
- Exchange
- EAT Nasdaq
- CORT Nasdaq
- Market Cap
- EAT 7.0B
- CORT 7.1B
- IPO Year
- EAT N/A
- CORT N/A
- Fundamental
- Price
- EAT $150.90
- CORT $70.84
- Analyst Decision
- EAT Hold
- CORT Strong Buy
- Analyst Count
- EAT 16
- CORT 4
- Target Price
- EAT $144.36
- CORT $142.00
- AVG Volume (30 Days)
- EAT 2.0M
- CORT 1.3M
- Earning Date
- EAT 04-29-2025
- CORT 05-05-2025
- Dividend Yield
- EAT N/A
- CORT N/A
- EPS Growth
- EAT 113.08
- CORT 8.36
- EPS
- EAT 7.16
- CORT 1.14
- Revenue
- EAT $5,130,500,000.00
- CORT $685,446,000.00
- Revenue This Year
- EAT $22.26
- CORT $35.85
- Revenue Next Year
- EAT $4.69
- CORT $35.22
- P/E Ratio
- EAT $21.00
- CORT $61.79
- Revenue Growth
- EAT 19.80
- CORT 30.93
- 52 Week Low
- EAT $56.27
- CORT $25.35
- 52 Week High
- EAT $192.22
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- EAT 55.66
- CORT 51.25
- Support Level
- EAT $135.00
- CORT $69.33
- Resistance Level
- EAT $152.82
- CORT $73.36
- Average True Range (ATR)
- EAT 5.97
- CORT 3.36
- MACD
- EAT 1.23
- CORT -0.23
- Stochastic Oscillator
- EAT 67.64
- CORT 45.66
About EAT Brinker International Inc.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.